Amyotrophic lateral sclerosis: new era, new challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Amyotrophic lateral sclerosis: new era, new challenges

Published:2022-05 Issue:5 Volume:21 Page:400-401
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Tang Lu,Fan Dongsheng

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference14 articles.

1. Emerging insights into the complex genetics and pathophysiology of ALS;Goutman;Lancet Neurol,2022

2. Recent advances in the diagnosis and prognosis of ALS;Goutman;Lancet Neurol,2022

3. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications;Chia;Lancet Neurol,2018

4. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial;Lancet Neurol,2017

5. Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients;Abe;Amyotroph Lateral Scler Frontotemporal Degener,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated multi-omics analysis identifies novel risk loci for amyotrophic lateral sclerosis in the Chinese population;2024-03-05

2. Introduction to Neurodegenerative Diseases;Advances in Medical Diagnosis, Treatment, and Care;2024-02-14

3. Circulating proteomic biomarkers for diagnosing sporadic amyotrophic lateral sclerosis: a cross-sectional study;Neural Regeneration Research;2023-11-08

4. “Huoling Shengji granule” for amyotrophic lateral sclerosis: protocol for a multicenter, randomized, double-blind, riluzole parallel controlled clinical trial;Frontiers in Aging Neuroscience;2023-05-09

5. Mendelian Randomization Analysis Reveals Statins Potentially Increase Amyotrophic Lateral Sclerosis Risk Independent of Peripheral Cholesterol-Lowering Effects;Biomedicines;2023-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3